The Prix Galien, considered the equivalent of the Nobel Prize in biopharmaceutical research, celebrates breakthrough innovations that progress our understanding in diagnosing, treating, and curing disease. The Best Public Sector Innovation award specifically recognises outstanding innovations in healthcare developed within or significantly supported by the public sector, spotlighting contributions that have profoundly impacted human health. Nominations were assessed on criteria of originality, clinical utility, knowledge contribution, impact, and independence from market factors.
The PRINCIPLE and PANORAMIC teams were honoured for their rapid implementation of adaptive platform trials, which significantly accelerated the evaluation of potential treatments for COVID-19 in community settings.
The awards were held in the evening of The Galien Forum at the Natural History Museum in London. Now in its third year, the forum is part of the Prix Galien UK’s annual celebration of excellence in the science of pharmaceuticals, vaccines, medical technologies and public health.
Professor Chris Butler, Professor of Primary Care at the Nuffield Department of Primary Care Health Sciences and co-Chief Investigator of the PRINCIPLE and PANORAMIC trials, said: ‘We are thrilled to receive this prestigious award, which is a testament to the hard work and dedication of our entire team. The PRINCIPLE and PANORAMIC trials have demonstrated the power of collaborative research in generating crucial evidence to inform patient care during a global health crisis.’
Read the full story on the The Nuffield Department of Primary Care Health Sciences website.